<DOC>
	<DOCNO>NCT01755598</DOCNO>
	<brief_summary>The purpose study evaluate protective efficacy two dos GSK Biologicals ' candidate TB vaccine pulmonary TB , compare placebo . The efficacy evaluate adult live TB endemic country age 18 - 50 year pulmonary TB occur frequently country age range . In addition , safety immunogenicity candidate tuberculosis vaccine evaluate subset volunteer .</brief_summary>
	<brief_title>Study Evaluate Efficacy GlaxoSmithKline ( GSK ) Biologicals ' Candidate Tuberculosis ( TB ) Vaccine Adults</brief_title>
	<detailed_description>Case Definitions : • First case definition : A subject clinical suspicion pulmonary TB disease , MTB complex identify sputum specimen , take initiation TB treatment , Xpert MTB/RIF and/or microbiological culture confirm HIV-negative time TB diagnosis . • Second case definition : A subject clinical suspicion pulmonary TB disease , MTB complex identify sputum specimen , take initiation TB treatment , Xpert MTB/RIF confirm HIV-negative time TB diagnosis . • Third case definition : A subject clinical suspicion pulmonary TB disease , MTB complex identify sputum specimen , take four week initiation TB treatment , Xpert MTB/RIF and/or microbiological culture confirm HIV-negative time TB diagnosis . • Fourth case definition : A subject clinical suspicion pulmonary TB disease , MTB complex identify sputum specimen , take four week initiation TB treatment , Xpert MTB/RIF and/or microbiological culture . • Fifth case definition : A subject clinician diagnose TB disease decide treat patient TB treatment .</detailed_description>
	<mesh_term>Tuberculosis</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Subjects , opinion investigator , comply requirement protocol . A male female , include , 18 50 year age time obtain informed consent . Written ( thumb print witness ) inform consent obtain subject . Baseline positive IGRA test result . Baseline negative HIV screen . Baseline negative clinical screening questionnaire negative sputum sample Pulmonary TB disease . Healthy subject chronic wellcontrolled disease establish medical history clinical examination . Female subject nonchildbearing potential may enrol study . Nonchildbearing potential define premenarche , current tubal ligation , hysterectomy , ovariectomy postmenopause . Female subject childbearing potential may enrol study , subject : practiced adequate contraception 25 day prior vaccination , negative pregnancy test day screen day first vaccination , agree continue adequate contraception entire vaccination period 2 month completion vaccination series . Current TB disease history TB disease and/or treatment TB . Use investigational nonregistered product study vaccine within 30 day precede first dose study vaccine , plan use study period . Planned administration/administration vaccine foreseen study protocol period start 30 day end 30 day dose vaccine . History previous administration experimental Mtb vaccine . Chronic administration immunosuppressant immunemodifying drug within six month prior first vaccine dose . Inhaled topical steroid allow . Any condition illness medication , opinion Investigator might interfere evaluation safety immunogenicity vaccine . Any confirm suspected immunosuppressive immunodeficient condition , base medical history physical examination . Planned participation participation another experimental protocol study . Concurrently participate another clinical study , time study period , subject expose investigational noninvestigational product . Administration immunoglobulins and/or blood product within 3 month precede first dose study vaccine plan administration study period . History reaction hypersensitivity likely exacerbate component vaccine . History medically confirm autoimmune disease . Pregnant lactate female . Female plan become pregnant planning discontinue contraceptive precaution vaccination period and/or 2 month completion vaccination series .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Positive Interferon-γ release assay</keyword>
	<keyword>Efficacy</keyword>
	<keyword>Adults</keyword>
	<keyword>Tuberculosis vaccine</keyword>
	<keyword>Endemic region</keyword>
</DOC>